← Alle mensen

NS

Neal Sule

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Patient-reported outcomes with belantamab mafodotin, pomalidomide, and dexamethasone versus bortezomib, pomalidomide,...
The Lancet. Haematology · 2025-11
Belantamab mafodotin plus pomalidomide-dexamethason bij myeloom: DREAMM-8 fase III
The New England journal of medicine · 1 augustus 2024
Belantamab mafodotin versus PomDex bij recidief myeloom: DREAMM-3 fase III
The Lancet. Haematology · 2023-10